PREVENT

Summary

To help improve the ability to detect dementia before symptoms develop and thereby increase access to early treatment.

The study purposes are to improve diagnosis of dementia and help measure effectiveness of future treatments. The specific aims are to identify the earliest features of dementia before symptoms can be detected and to understand how they progress over a period of several years. Without your help, it would be impossible to determine if the values seen in patients with transient ischemic attack are part of the normal variability between individuals or not.

Eligibility

Currently recruiting participants: Yes

Eligible gender: Male, Female, Transgender, Other

Eligible ages: 45 to 80

Accepts healthy participants: Yes

Inclusion criteria:

Participants will be eligible to participate in either study if all of the following conditions are present:

1. Ambulatory
2. Probable TIA
3. English speaking or translator available
4. Competent to provide consent and report symptoms
5. Have no exclusion to MRI
6. Age 45-80

Exclusion criteria:

1. Non-Ambulatory
2. Not TIA or minor stroke
3. Non English speaking or translator not available
4. Not Competent to provide consent and report symptoms
5. Have exclusion to MRI
6. Participant is deaf or hard of hearing

Participate

Fill out the following form if you want to participate in this research

Method of contact

Collection of personal information
Your personal information is collected under the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If you have any questions about the collection or use of this information, please visit our Access to Information page.

Additional information

Contact information

Supriya Save 403 944 2370 supriya.save@ahs.ca Karyn Fischer karyn.fischer@ahs.ca Dr. Philip Barber pabarber@ucalgary.ca

Principal investigator:

Philip Barber

Clinical trial:

No

REB-ID:

REB13-0240